A Single Centre, Open Label, One Sequence, Cross-over Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Single Inhaled Doses of Nemiralisib in Healthy Subjects
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2018
At a glance
- Drugs Nemiralisib (Primary) ; Itraconazole
- Indications Asthma; Chronic obstructive pulmonary disease; Immunodeficiency disorders
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 08 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 02 Feb 2018 Status changed from not yet recruiting to recruiting.
- 15 Jan 2018 New trial record